Anti-CD31 抗体 [TLD-3A12]
Anti-CD31 antibody [TLD-3A12]
- Lab Essentials
- 詳細を見る
3
(6 Reviews)
|
(101 Publications)
Mouse Monoclonal CD31 antibody. Suitable for IHC-Fr and reacts with Rat samples. Cited in 101 publications. Immunogen corresponding to Cell preparation containing Pecam1 protein.
別名を表示する
CD31, Pecam, Pecam1, Platelet endothelial cell adhesion molecule, PECAM-1
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - Anti-CD31 antibody [TLD-3A12] (AB64543)
Immunohistochemical staining of rat spleen cryosection with Mouse anti Rat CD31 (ab64543)
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - Anti-CD31 antibody [TLD-3A12] (AB64543)
Immunohistochemical staining of rat brain cryosection with Mouse anti Rat CD31 (ab64543)
- IHC-Fr
AbReview25216****
Immunohistochemistry (Frozen sections) - Anti-CD31 antibody [TLD-3A12] (AB64543)
ab64543 staining CD31 in rat brain tissue by Immunohistochemistry (Frozen sections). The sections were fixed in paraformaldehyde prior to blocking with 5% donkey serum, BSA 1%, Triton 1.5% for 2 hours at room temperature. The primary antibody was diluted 1/200 in PBS/5% Donkey serum and incubated with the sample for 12 hours at 4°C. An Alexa Fluor® 555-conjugated donkey anti-mouse polyclonal was used as the secondary antibody, diluted 1/200.
This image is courtesy of Valley Lasry.
- IHC
CiteAb
Immunohistochemistry - Anti-CD31 antibody [TLD-3A12] (AB64543)
Immunohistochemistry using Anti-CD31 antibody [TLD-3A12], ab64543. Publication image from Huang, S. M. et al., 2013, J Biomed Sci, 23876213. Legend direct from paper.
Analysis of angiogenesis and blood vessel density in ASC-treated tissue. (A-C) After three weeks of treatment, the tissues of the wound edge were subjected to histological examination. Compared with the control group (A), the capillary density in the dermis was clearly increased in the ASC-treated group (B). Arrows indicate vessel formation and proliferation sites containing erythrocytes in each wound. E : epidermis; M : muscle layer; U : ulcer. Bar : 500 µm. (C) Tissue lysates from re-epithelialized skin tissue of control and ASC-treated groups were analyzed with immunoblot analysis against CD31 and HuR (a loading control). (D-F) Three weeks after ASC treatment, ulcerated tissues were removed and processed into 8 µm frozen sections. Slides were stained with CD31 (green) and DAPI, a fluorescent nuclear stain (blue). Bar : 50 µm. Representative images of the control (D) and ASC (E) group are shown. (F) The blood vessel density was evaluated in the control and ASC-treated groups. The data represent the mean ± SEM of eight rats. *p < 0.01.
- IHC
CiteAb
Immunohistochemistry - Anti-CD31 antibody [TLD-3A12] (AB64543)
Immunohistochemistry using Anti-CD31 antibody [TLD-3A12], ab64543. Publication image from Huang, S. M. et al., 2013, J Biomed Sci, 23876213. Legend direct from paper.
Engrafted CM-DiI-labeled ASCs were expressed within the endothelial cells. (A-C) Images obtained from 16 µm sections frozen 14 days after the injection of CM-DiI-labeled ASCs (red fluorescence) into tissue with radiation ulcers. Phase contrast (A), red fluorescence (B) and overlay images (C). Bar : 200 µm. (D-K) Confocal images were acquired from 8 µm sections frozen 14 days after the injection of CM-DiI-labeled ASCs and immunostained with vWF (D-G) or CD31 (H-K). Differential interference contrast image (D and H). Red staining indicates CM-DiI-labeled ASCs (E and I). Green staining indicates vWF (F) and CD31 (J). Overlay image (G and K).
関連する標識済み抗体及び組成の異なる製品 (1)
-
519 FITC
FITC Anti-CD31 antibody [TLD-3A12]
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (101)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:113332 PubMed40933643
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 23:524 PubMed40346622
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2409744 PubMed39656938
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:23380 PubMed39379568
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:7855 PubMed39245680
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2401844 PubMed38884204
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neuroscience 18:1254600 PubMed38510463
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38338969
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2309133 PubMed38225729
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of medical sciences 21:137-150 PubMed38164350
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com